Empire Financial Management Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $277K | Buy |
5,990
+50
| +0.8% | +$2.32K | 0.08% | 173 |
|
|
2025
Q1 | $362K | Hold |
5,940
| – | – | 0.11% | 161 |
|
|
2024
Q4 | $336K | Buy |
+5,940
| New | +$336K | 0.1% | 164 |
|
|
2024
Q2 | – | Sell |
-11,940
| Closed | -$648K | – | 201 |
|
|
2024
Q1 | $648K | Sell |
11,940
-5,086
| -30% | -$276K | 0.21% | 123 |
|
|
2023
Q4 | $874K | Sell |
17,026
-12,819
| -43% | -$658K | 0.34% | 79 |
|
|
2023
Q3 | $1.73M | Sell |
29,845
-460
| -2% | -$26.7K | 0.75% | 42 |
|
|
2023
Q2 | $1.94M | Buy |
30,305
+25,265
| +501% | +$1.62M | 0.77% | 42 |
|
|
2023
Q1 | $349K | Buy |
+5,040
| New | +$349K | 0.14% | 150 |
|